Ordinary Adjustment | Solactive Eli Lilly Value Chain Index | Effective Date 8th May 2025
Solactive Eli Lilly Value Chain Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th May 2025:
| SAMSUNG BIOLOGICS CO LTD |
| ELI LILLY & CO |
| LONZA GROUP AG |
| THERMO FISHER SCIENTIFIC INC |
| CHUGAI PHARMACEUTICAL CO LTD ORD |
| ICON PLC |
| UNITED THERAPEUTICS CORP |
| SHIONOGI & CO LTD ORD |
| INCYTE CORP |
| HALOZYME THERAPEUTICS INC |
| TECAN GROUP AG-REG |
| BACHEM HOLDING AG-REG B |
| AMPHASTAR PHARMACEUTICALS INC |
| VEEVA SYSTEMS INC |
| SCHRODINGER INC |